HBV core antigen (HBc) upregulates miR-135a-5p in sEVs to inhibit VAMP2 function, promoting anti-apoptotic properties and drug resistance in HCC cells (60). This evidence concerns the gene VAMP2 and hepatocellular carcinoma.